Hansa Biopharma signs EUR115m IDEFIRIX licensing deal with SERB
Lupin receives tentative FDA approval for Revefenacin Inhalation Solution
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
Akeso reports results from Phase II trial of ligufalimab combination therapy in AML
US FDA approves Datar Cancer Genetics' comprehensive genomic profiling assay for solid tumours
US FDA approves Lupin's Famotidine Injection USP
Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma
Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook